21st Century Cures: One Year Later

Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo.), the architects behind the biomedical innovation law 21st Century Cures Act, talk with Bloomberg Law about the impact of their legislation to spur new drugs and devices one year after it became law.